Innomar Strategies Reaches Agreement with the Government of Canada to Support COVID-19 Vaccine Distribution 

OAKVILLE, Ontario – Innomar Strategies, a part of AmerisourceBergen, has reached an agreement with the Government of Canada to support the distribution of COVID-19 vaccines across Canada. The agreement was announced today by the Honourable Anita Anand, Minister of Public Services and Procurement and the Honourable Patty Hajdu, Minister of Health.

As part of the agreement, Innomar will work with FedEx Express Canada to provide an end-to-end logistics solution that protects product viability throughout transport and enables safe and timely vaccine administration in each province and territory. To support access, Innomar will provide third-party logistics (3PL) and importation services, including scalable storage solutions, to accommodate distribution efforts. Innomar will use its GMP-compliant facilities to safely and securely store and handle COVID-19 vaccines. The storage facilities—which are equipped to store complex pharmaceutical products, including those with cold chain requirements—are temperature-mapped and have a validated monitoring system to protect against temperature excursions.

“As the leading patient support provider in the Canadian specialty pharmaceutical market, Innomar has been working throughout the COVID-19 pandemic to continuously ensure patient access to the medications they need,” said Guy Payette, president of Innomar Strategies. “This agreement is another extension of the role we play in improving product access and increasing supply chain efficiency in Canada. We are honored to work with FedEx and the Government of Canada to help ensure patients receive timely access to a COVID-19 vaccine.”

To learn more about the agreement, visit the Government of Canada’s website: https://www.canada.ca/en/public-services-procurement/news/2020/12/government-of-canada-awards-contract-to-distribute-covid-19-vaccine-from-coast-to-coast-to-coast.html 

###

About Innomar Strategies
Innomar Strategies, a part of AmerisourceBergen, is the leading patient support provider in the Canadian specialty biopharmaceutical market. We deliver end-to-end commercialization solutions to improve product access, increase supply chain efficiency and enhance patient care. Strategic consulting, patient support programs, nursing, and clinical services, and specialty pharmacy and logistics are just a few of our key areas of specialization. We partner closely with manufacturers, healthcare providers, pharmacies and payers to ensure patients have consistent and reliable access to specialty medication. With our integrated approach and commitment to best-in-class care, Innomar Strategies helps navigate the patient journey to optimize health outcomes. Visit us at www.innomar-strategies.com.

About AmerisourceBergen                     
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work—and powered by our 22,000 associates—we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500, with more than $175 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. Learn more at amerisourcebergen.com.